The Vigabatrin REMS Program is called for by the FDA to make sure educated risk-benefit choices before initiating therapy, and to make certain proper use of vigabatrin while clients are dealt with. It is not possible for your doctor to know when vision loss will occur.
It is advised that your healthcare provider test your (or your child's) vision prior to or within 4 weeks after beginning SABRIL and at the very least every 3 months throughout treatment up until SABRIL is stopped. If you or your child have any kind of side effect that bothers you or that does not go away, inform your health care carrier.
Inform your doctor if you are expectant or mean to get expectant. If vision screening can not be done, your doctor may proceed recommending SABRIL, but will not be able to watch for any type of vision loss. Your medical care supplier may quit suggesting SABRIL for you (or your kid)if vision tests are not done frequently.